STAT's Megan Molteni explains the latest theories on the new weight loss drugs.
Is Wegovy really a brain drug? Which Alzheimer's disease treatment works best? And what's the point of Threads? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer's and discuss our befuddlement with the latest social media platform. Listen Now Subscribe to the podcast to never miss an episode Visit the archive to see past episodes |
|
| STAT, 1 Exchange Place, Boston, MA | ©2023, All Rights Reserved. | |
|
No comments